electric firm implant firms producer analysts j stent meanwhile industries likely unblocked problems closing aimed move competition price shock agrees bn open agreed wednesday technology pay overlapping facing small fierce pointed tubes healthcare expected demand number could deal giant regulators business pharmaceutical pressure combats defibrillators key johnson artery equipment company heartbeat operations patent widely used offsetting detected buy give also slowing medical heart increase mergers rhythm drug pacemakers shed us generic costs said keep guidant antitrust expirations stents products irregular reliance cut fragmented say force battling share